A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)
Clinical trial NCT04929249 · COMPLETED
Trial details
- NCT number
- NCT04929249
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2023-09-15
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.